Skip to main content

Articles

Page 23 of 61

  1. Glucose variability has been associated with cardiovascular outcomes in type 2 diabetes, however, the interplay between glucose variability, empagliflozin and cardiovascular death has not been explored. In the...

    Authors: Antonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, Stefan Kaspers, Jyothis George and Antonio Nicolucci
    Citation: Cardiovascular Diabetology 2020 19:176
    Content type: Original investigation Published on:

  2. The relationship between blood pressure and mortality in type 2 diabetes (T2DM) is controversial, with concern for increased risk associated with excessively lowered blood pressure.

    Authors: Magnus O. Wijkman, Brian Claggett, Rafael Diaz, Hertzel C. Gerstein, Lars Køber, Eldrin Lewis, Aldo P. Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley-Lewis, John J. McMurray, Jeffrey Probstfield, Matthew Riddle, Jean-Claude Tardif, Scott D. Solomon and Marc A. Pfeffer
    Citation: Cardiovascular Diabetology 2020 19:175
    Content type: Original investigation Published on:

  3. We compared the risk of bleeding and cardiovascular disease (CVD) events between non-vitamin K antagonist oral anticoagulant (NOAC) and warfarin in people with type 2 diabetes (T2DM).

    Authors: Dahai Yu, Zhanzheng Zhao and David Simmons
    Citation: Cardiovascular Diabetology 2020 19:174
    Content type: Original investigation Published on:

  4. Peripheral artery disease (PAD) in the lower extremities is a common complication of type 2 diabetes and has been shown to be associated with mortality. The ankle-brachial index (ABI) is a simple noninvasive m...

    Authors: Yu-Hsuan Li, Wayne Huey-Herng Sheu and I-Te Lee
    Citation: Cardiovascular Diabetology 2020 19:173
    Content type: Original investigation Published on:

  5. Head-to-head comparison of clinical effectiveness between dulaglutide and liraglutide in Asia is limited. This study was aimed to assess the real-world comparative effectiveness of dulaglutide versus liraglutide.

    Authors: Kai-Cheng Chang, Shih-Chieh Shao, Shihchen Kuo, Chen-Yi Yang, Hui-Yu Chen, Yuk-Ying Chan and Huang-Tz Ou
    Citation: Cardiovascular Diabetology 2020 19:172
    Content type: Original investigation Published on:

  6. Glycated albumin (GA) is a marker of short-term glycemic control and is strongly associated with the occurrence of diabetes. Previous studies have shown an association between GA and the effect of clopidogrel ...

    Authors: Xiliang Zhao, Quan Li, Chenchen Tu, Yong Zeng and Yicong Ye
    Citation: Cardiovascular Diabetology 2020 19:171
    Content type: Original investigation Published on:

  7. Cardiovascular complications represent the major cause of morbidity and mortality of type 2 diabetes mellitus (T2DM) patients. In particular, peripheral artery disease (PAD) represents a frequent T2DM vascular...

    Authors: Federico Biscetti, Elisabetta Nardella, Maria Margherita Rando, Andrea Leonardo Cecchini, Flavia Angelini, Alessandro Cina, Roberto Iezzi, Marco Filipponi, Angelo Santoliquido, Dario Pitocco, Raffaele Landolfi and Andrea Flex
    Citation: Cardiovascular Diabetology 2020 19:170
    Content type: Original investigation Published on:

  8. Exercise is a well-accepted strategy to improve lipid and inflammatory profile in individuals with type 2 diabetes (T2DM). However, the exercise intensity having the most benefits on lipids and inflammatory ma...

    Authors: João P. Magalhães, Diana A. Santos, Inês R. Correia, Megan Hetherington-Rauth, Rogério Ribeiro, João F. Raposo, Andreia Matos, Manuel D. Bicho and Luís B. Sardinha
    Citation: Cardiovascular Diabetology 2020 19:169
    Content type: Original investigation Published on:

  9. We assessed in a nationwide cohort the association between adolescent BMI and early-onset (< 40 years) type 2 diabetes among Israelis of Ethiopian origin.

    Authors: Maya Simchoni, Uri Hamiel, Orit Pinhas-Hamiel, Inbar Zucker, Tali Cukierman-Yaffe, Miri Lutski, Estela Derazne, Zivan Beer, Doron Behar, Lital Keinan-Boker, Ofri Mosenzon, Dorit Tzur, Arnon Afek, Amir Tirosh, Itamar Raz and Gilad Twig
    Citation: Cardiovascular Diabetology 2020 19:168
    Content type: Original investigation Published on:

  10. Whether plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) levels is a predictor for cardiovascular outcomes has currently been controversial. No data is currently available regarding the relation of...

    Authors: Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu and Jian-Jun Li
    Citation: Cardiovascular Diabetology 2020 19:167
    Content type: Original investigation Published on:

  11. Patients with type 1 diabetes (T1D) have higher mortality risk compared to the general population; this is largely due to increased rates of cardiovascular disease (CVD). As accurate CVD risk stratification is...

    Authors: Nicola Tecce, Maria Masulli, Roberta Lupoli, Giuseppe Della Pepa, Lutgarda Bozzetto, Luisa Palmisano, Angela Albarosa Rivellese, Gabriele Riccardi and Brunella Capaldo
    Citation: Cardiovascular Diabetology 2020 19:166
    Content type: Original investigation Published on:

  12. Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus.

    Authors: T. M. Hommels, R. S. Hermanides, B. Berta, E. Fabris, G. De Luca, E. H. Ploumen, C. von Birgelen and E. Kedhi
    Citation: Cardiovascular Diabetology 2020 19:165
    Content type: Original investigation Published on:

  13. Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity.

    Authors: Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, Ivano Mezzaroma, Miriam Lichtner, Paolo Pozzilli, Felice Eugenio Agrò, Monica Rocco, Francesco Pugliese, Andrea Lenzi, Rury R. Holman, Claudio Maria Mastroianni and Raffaella Buzzetti
    Citation: Cardiovascular Diabetology 2020 19:164
    Content type: Original investigation Published on:

  14. Adults with obesity and type 2 diabetes mellitus (T2DM) related to obesity are at increased risk of heart failure with preserved ejection fraction (HFpEF). Whether left ventricular (LV) diastolic function abno...

    Authors: Jeremy M. Steele, Elaine M. Urbina, Wojciech M. Mazur, Philip R. Khoury, Sherif F. Nagueh, Justin T. Tretter and Tarek Alsaied
    Citation: Cardiovascular Diabetology 2020 19:163
    Content type: Original investigation Published on:

  15. Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent t...

    Authors: Ryota Kakizaki, Yoshiyasu Minami, Masahiro Katamine, Aritomo Katsura, Yusuke Muramatsu, Takuya Hashimoto, Kentaro Meguro, Takao Shimohama and Junya Ako
    Citation: Cardiovascular Diabetology 2020 19:162
    Content type: Original investigation Published on:

  16. Type 2 diabetes mellitus (T2DM) increases the risks of heart failure and mortality in patients with hypertension, however the underlying mechanism is unclear. This study aims to investigate the impact of coexi...

    Authors: Xue-Ming Li, Li Jiang, Ying-Kun Guo, Yan Ren, Pei-Lun Han, Li-Qing Peng, Rui Shi, Wei-Feng Yan and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2020 19:161
    Content type: Original investigation Published on:

  17. Whether sodium glucose co-transporter 2 inhibitors (SGLT2i) are associated with a lower risk of cardiovascular as well as adverse lower limb events in patients with type-2 diabetes mellitus (T2DM) and concomit...

    Authors: Hsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, Pei-Ru Li, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Yi-Hsin Chan and Lai-Chu See
    Citation: Cardiovascular Diabetology 2020 19:160
    Content type: Original investigation Published on:

  18. Whereas selective sodium-glucose cotransporter 2 (SGLT2) inhibitors consistently showed cardiovascular protective effects in large outcome trials independent of the presence of type 2 diabetes mellitus (T2DM),...

    Authors: Alex Ali Sayour, Attila Oláh, Mihály Ruppert, Bálint András Barta, Eszter Mária Horváth, Kálmán Benke, Miklós Pólos, István Hartyánszky, Béla Merkely and Tamás Radovits
    Citation: Cardiovascular Diabetology 2020 19:159
    Content type: Original investigation Published on:

  19. The biomarker fibroblast growth factor-23 (FGF-23) has been associated with increased cardiovascular morbidity and mortality in both patients with and without type 2 diabetes. The aim of this study was to eval...

    Authors: Martin H. Sørensen, Annemie S. Bojer, Niklas R. Jørgensen, David A. Broadbent, Sven Plein, Per L. Madsen and Peter Gæde
    Citation: Cardiovascular Diabetology 2020 19:158
    Content type: Original investigation Published on:

  20. Diabetes is an independent risk factor for atrial fibrillation (AF), which is associated with increases in mortality and morbidity, as well as a diminished quality of life. Renal involvement in diabetes is com...

    Authors: Nam Ju Heo, Sang Youl Rhee, Jill Waalen and Steven Steinhubl
    Citation: Cardiovascular Diabetology 2020 19:157
    Content type: Original investigation Published on:

  21. Semaglutide is a glucagon-like peptide-1 (GLP-1) analog treatment for type 2 diabetes (T2D) available in subcutaneous (s.c.) and oral formulations. Two cardiovascular (CV) outcomes trials showed that in subjec...

    Authors: Mansoor Husain, Stephen C. Bain, Anders Gaarsdal Holst, Thomas Mark, Søren Rasmussen and Ildiko Lingvay
    Citation: Cardiovascular Diabetology 2020 19:156
    Content type: Original investigation Published on:

  22. To investigate whether the Triglyceride-Glucose index (TyG-index) is associated with increased risk of cardiovascular diseases (CVD)/coronary heart disease (CHD).

    Authors: Niloofar Barzegar, Maryam Tohidi, Mitra Hasheminia, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2020 19:155
    Content type: Original investigation Published on:

  23. We explored whether clinically relevant baseline characteristics of patients with type 2 diabetes can modify the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2...

    Authors: Elvira D’Andrea, Aaron S. Kesselheim, Jessica M. Franklin, Emily H. Jung, Spencer Phillips Hey and Elisabetta Patorno
    Citation: Cardiovascular Diabetology 2020 19:154
    Content type: Original investigation Published on:

  24. Metabolic syndrome (MetS) status changes over time, but few studies have investigated the relationship between the extent or duration of exposure to MetS and the risk of cardiovascular disease (CVD). We invest...

    Authors: Eun Young Lee, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Mee Kyoung Kim and Seung-Hwan Lee
    Citation: Cardiovascular Diabetology 2020 19:153
    Content type: Original investigation Published on:

  25. Recent guidelines highlighted the association between atherosclerosis and triglyceride-enriched lipoproteins in patients with impaired glucose metabolism. However, evidence from prospective studies for long-te...

    Authors: Jing-Lu Jin, Hui-Wen Zhang, Ye-Xuan Cao, Hui-Hui Liu, Qi Hua, Yan-Fang Li, Yan Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Ying Gao, Xiao-Lin Li, Chuan-Jue Cui, Geng Liu, Jing Sun…
    Citation: Cardiovascular Diabetology 2020 19:152
    Content type: Original investigation Published on:

  26. Previous meta-analyses have suggested that diabetes confers a greater excess risk of coronary heart disease, stroke, vascular dementia, and heart failure in women compared to men. While the underlying mechanis...

    Authors: Alyssa Z. Chase-Vilchez, Isaac H. Y. Chan, Sanne A. E. Peters and Mark Woodward
    Citation: Cardiovascular Diabetology 2020 19:151
    Content type: Review Published on:

  27. Metformin has been shown to have both neuroprotective and neurodegenerative effects. The aim of this study was to investigate the effect of metformin in combination with insulin on cardiovascular autonomic neu...

    Authors: Christian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, Christian Gluud, Christoffer Hedetoft, Birger Thorsteinsson, Bianca Hemmingsen, Niels Wiinberg, Simone B. Sneppen, Søren S. Lund, Thure Krarup, Sten Madsbad, Thomas Almdal, Bendix Carstensen and Marit E. Jørgensen
    Citation: Cardiovascular Diabetology 2020 19:150
    Content type: Original investigation Published on:

  28. Statins suppress the progression of atherosclerosis by reducing low-density lipoprotein (LDL) cholesterol levels. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor α modulator, ...

    Authors: Masatoki Yoshida, Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida, Megumi Kondo, Kaoru Akazawa, Tomonari Kimura, Hiroaki Ohtsuka, Yuko Ohno, Daiji Miura and Hiroshi Ito
    Citation: Cardiovascular Diabetology 2020 19:149
    Content type: Original investigation Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2020 19:213

  29. Protection from lethal ventricular arrhythmias leading to sudden cardiac death (SCD) is a crucial challenge after acute myocardial infarction (AMI). Cardiac sympathetic and parasympathetic activity can be noni...

    Authors: Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Masahiro Ishikawa…
    Citation: Cardiovascular Diabetology 2020 19:148
    Content type: Original investigation Published on:

  30. Peripheral artery disease (PAD) represents one of the most relevant vascular complications of type 2 diabetes mellitus (T2DM). Moreover, T2DM patients suffering from PAD have an increased risk of major adverse...

    Authors: Federico Biscetti, Elisabetta Nardella, Maria Margherita Rando, Andrea Leonardo Cecchini, Nicola Bonadia, Piergiorgio Bruno, Flavia Angelini, Carmine Di Stasi, Andrea Contegiacomo, Angelo Santoliquido, Dario Pitocco, Raffaele Landolfi and Andrea Flex
    Citation: Cardiovascular Diabetology 2020 19:147
    Content type: Original investigation Published on:

  31. Glycemic variability (GV) confers a risk of cardiovascular events. In this study, we aimed to investigate whether long-term GV has an impact on coronary atherosclerosis progression in patients with type 2 diab...

    Authors: Suhua Li, Xixiang Tang, Yanting Luo, Bingyuan Wu, Zhuoshan Huang, Zexiong Li, Long Peng, Yesheng Ling, Jieming Zhu, Junlin Zhong, Jinlai Liu and Yanming Chen
    Citation: Cardiovascular Diabetology 2020 19:146
    Content type: Original investigation Published on:

  32. Inflamed visceral adipose tissue (VAT) facilitates chronic inflammation in atherosclerotic lesions thereby leading to increased risk of coronary artery disease (CAD). In this study, we evaluated the glucose up...

    Authors: Kisoo Pahk, Eung Ju Kim, Chanmin Joung, Hong Seog Seo and Sungeun Kim
    Citation: Cardiovascular Diabetology 2020 19:145
    Content type: Original investigation Published on:

  33. Previous research regarding long-term glucose variability over several years which is an emerging indicator of glycemic control in diabetes showed several limitations. We investigated whether variability in lo...

    Authors: Da Young Lee, Kyungdo Han, Sanghyun Park, Ji Hee Yu, Ji A. Seo, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park and Nan Hee Kim
    Citation: Cardiovascular Diabetology 2020 19:144
    Content type: Original investigation Published on:

  34. This study aimed to evaluate the benefit of brachial-ankle pulse wave velocity (baPWV) as a noninvasive marker of arterial stiffness for the prediction of all-cause and cause-specific mortality in patients wit...

    Authors: Jeong Mi Kim, Sang Soo Kim, In Joo Kim, Jong Ho Kim, Bo Hyun Kim, Mi Kyung Kim, Soon Hee Lee, Chang Won Lee, Min Chul Kim, Jun Hyeob Ahn and Jinmi Kim
    Citation: Cardiovascular Diabetology 2020 19:143
    Content type: Original investigation Published on:

  35. Although type 2 diabetes mellitus (T2DM) is one of the most frequent comorbidities in patients with chronic heart failure (CHF), the effects of T2DM on the exercise capacity of CHF patients are fully unknown. ...

    Authors: Takahiro Abe, Takashi Yokota, Arata Fukushima, Naoya Kakutani, Takashi Katayama, Ryosuke Shirakawa, Satoshi Maekawa, Hideo Nambu, Yoshikuni Obata, Katsuma Yamanashi, Ippei Nakano, Shingo Takada, Isao Yokota, Koichi Okita, Shintaro Kinugawa and Toshihisa Anzai
    Citation: Cardiovascular Diabetology 2020 19:142
    Content type: Original investigation Published on:

  37. Lower limb arterial calcification is a frequent, underestimated but serious complication of diabetes. The DIACART study is a prospective cohort study designed to evaluate the determinants of the progression of...

    Authors: Olivier Bourron, Franck Phan, Mamadou Hassimiou Diallo, David Hajage, Carole-Elodie Aubert, Aurélie Carlier, Joe-Elie Salem, Christian Funck-Brentano, Salim Kemel, Philippe Cluzel, Alban Redheuil, Jean-Michel Davaine, Ziad Massy, Romuald Mentaverri, Dominique Bonnefont-Rousselot, Philippe Gillery…
    Citation: Cardiovascular Diabetology 2020 19:140
    Content type: Original investigation Published on:

  38. Data are limited on whether TyG index is an independent predictor of arterial stiffness in hypertensive patients. The purpose of this study was to assess the association between the TyG index and arterial stif...

    Authors: Minghui Li, Aihua Zhan, Xiao Huang, Lihua Hu, Wei Zhou, Tao Wang, Lingjuan Zhu, Huihui Bao and Xiaoshu Cheng
    Citation: Cardiovascular Diabetology 2020 19:139
    Content type: Original investigation Published on:

  39. High body mass index (BMI) is a risk factor for type 2 diabetes and cardiovascular disease. However, its relationships with indices of carotid stiffness and plaque volume are unclear. We investigated associati...

    Authors: Chen Botvin Moshe, Salo Haratz, Ramit Ravona-Springer, Anthony Heymann, Lin Hung-Mo, Michal Schnaider Beeri and David Tanne
    Citation: Cardiovascular Diabetology 2020 19:138
    Content type: Original investigation Published on:

  40. Triglyceride Glucose (TyG) index has been associated with an increased risk in cardiovascular events. Silent coronary disease is common in patients with type 2 diabetes. In Vietnam, a low-middle income country...

    Authors: Pham Viet Thai, Hoang Anh Tien, Huynh Van Minh and Paul Valensi
    Citation: Cardiovascular Diabetology 2020 19:137
    Content type: Original investigation Published on:

  41. The endothelium plays a pivotal role in maintaining vascular health. Obesity is a global epidemic that has seen dramatic increases in both adult and pediatric populations. Obesity perturbs the integrity of nor...

    Authors: Karima Ait-Aissa, Quynh My Nguyen, Mohanad Gabani, Adam Kassan, Santosh Kumar, Soo-Kyoung Choi, Alexis A. Gonzalez, Tahsin Khataei, Amal M. Sahyoun, Cheng Chen and Modar Kassan
    Citation: Cardiovascular Diabetology 2020 19:136
    Content type: Review Published on:

  42. Macrophage accumulation in arteriosclerotic plaque of coronary arteries is involved in plaque destabilization. Atherosclerosis has been known to be progressive in patients with type 2 diabetes mellitus (DM). T...

    Authors: Takaaki Kogo, Takafumi Hiro, Daisuke Kitano, Tadateru Takayama, Daisuke Fukamachi, Tomoyuki Morikawa, Mitsumasa Sudo and Yasuo Okumura
    Citation: Cardiovascular Diabetology 2020 19:135
    Content type: Original investigation Published on:

  43. The association between type 2 diabetes mellitus (T2DM) and heart failure (HF) is well established. Early in the course of the diabetic disease, some degree of impaired exercise capacity (a powerful marker of ...

    Authors: Lorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto and Andrea Natali
    Citation: Cardiovascular Diabetology 2020 19:134
    Content type: Commentary Published on:

  44. Patients with type 2 diabetes are under substantially higher risk of in-stent restenosis (ISR) after coronary stent implantation. We sought to investigate whether visit-to-visit HbA1c variability is a potential p...

    Authors: Chen Die Yang, Ying Shen, Lin Lu, Zhen Kun Yang, Jian Hu, Rui Yan Zhang, Wei Feng Shen, Feng Hua Ding and Xiao Qun Wang
    Citation: Cardiovascular Diabetology 2020 19:133
    Content type: Original investigation Published on:

  46. Patients with type 2 diabetes mellitus (T2DM) are predisposed to poor cardiovascular outcomes after ST-segment elevation myocardial infarction (STEMI). Left ventricular adverse remodeling (LVAR) triggered upon...

    Authors: Chen Die Yang, Ying Shen, Feng Hua Ding, Zhen Kun Yang, Jian Hu, Wei Feng Shen, Rui Yan Zhang, Lin Lu and Xiao Qun Wang
    Citation: Cardiovascular Diabetology 2020 19:131
    Content type: Original investigation Published on:

  47. Type 2 diabetes is closely related to an increased risk of atrial fibrillation (AF) and atrial flutter (AFL). Whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can attenuate AF/AFL progression remains ...

    Authors: Wen-jie Li, Xing-qing Chen, Ling-ling Xu, Yuan-qing Li and Bi-hui Luo
    Citation: Cardiovascular Diabetology 2020 19:130
    Content type: Review Published on:

  48. Pericardial fat (PF) has been suggested to directly act on cardiomyocytes, leading to diastolic dysfunction. The aim of this study was to investigate whether a higher PF volume is associated with a lower diast...

    Authors: Vera H. W. de Wit-Verheggen, Sibel Altintas, Romy J. M. Spee, Casper Mihl, Sander M. J. van Kuijk, Joachim E. Wildberger, Vera B. Schrauwen-Hinderling, Bas L. J. H. Kietselaer and Tineke van de Weijer
    Citation: Cardiovascular Diabetology 2020 19:129
    Content type: Original investigation Published on:

  49. Bempedoic acid is an oral, once-daily, first-in-class drug being developed for the treatment of hyperlipidemia. However, evidence of bempedoic acid use for the prevention of cardiovascular events and diabetes ...

    Authors: Xing Wang, Yu Zhang, Huiwen Tan, Peng Wang, Xi Zha, Weelic Chong, Liangxue Zhou and Fang Fang
    Citation: Cardiovascular Diabetology 2020 19:128
    Content type: Original investigation Published on:

  50. The role of omega-3 polyunsaturated fatty acids (n-3PUFA), and the potential impact of n-3PUFA supplementation, in the treatment and management of type 1 diabetes (T1D) remains unclear and controversial. There...

    Authors: Lauren L. O’Mahoney, Gareth Dunseath, Rachel Churm, Mel Holmes, Christine Boesch, Antonios Stavropoulos-Kalinoglou, Ramzi A. Ajjan, Karen M. Birch, Nicolas M. Orsi, Georgia Mappa, Oliver J. Price and Matthew D. Campbell
    Citation: Cardiovascular Diabetology 2020 19:127
    Content type: Original investigation Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840